Purchase by Foresite Capital Management IV, LLC / Foresite Capital Fund IV, L.P. / Foresite Capital Management V, LLC / Foresite Capital Fund V, L.P. / Foresite Capital Opportunity Management V, LLC / Foresite Capital Opportunity Fund V, L.P. / Foresite Capital VI-A Management, L
Eikon Therapeutics, Inc. Common Stock · BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) · Now $10.79
Post-detection moves
1h
—
1d
—
3d
—
7d
—
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS